Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke.

Martin-Villalba, A; Hahne, M; Kleber, S; Vogel, J; Falk, W; Schenkel, J; Krammer, P H

Martin-Villalba, A; Hahne, M; Kleber, S; Vogel, J; Falk, W; Schenkel, J; Krammer, P H.

Affiliation

Martin-Villalba A; Tumorimmunology Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. c50@ix.urz.uni-heidelberg.de

Cell Death Differ ; 8(7): 679-86, 2001 Jul.

Article in En | MEDLINE | ID: mdl-11464212

Subject(s)

Membrane Glycoproteins/antagonists & inhibitors; Membrane Glycoproteins/metabolism; Stroke/drug therapy; Stroke/pathology; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Tumor Necrosis Factor-alpha/metabolism; Animals; Antibodies/immunology; Antibodies/pharmacology; Antibodies/therapeutic use; Apoptosis/drug effects; Brain Ischemia/drug therapy; Brain Ischemia/metabolism; Brain Ischemia/pathology; Cells, Cultured; Disease Models, Animal; Fas Ligand Protein; Immunohistochemistry; Inflammation/metabolism; Inflammation/pathology; Membrane Glycoproteins/immunology; Mice; Mice, Inbred C57BL; Mice, Knockout; Stroke/metabolism; Tumor Necrosis Factor-alpha/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Tumor Necrosis Factor-alpha / Stroke Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Death Differ Year: 2001 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links